Biomedical subjects

A Ambegaonkar

Publications and source records attributed to A Ambegaonkar.

3 recordsLinked to original sources

PubMed1999

Computer-assisted evaluation of antibiotic regimen coverage and cost.

Evaluation of the cost-effectiveness of antibiotic regimens has become an essential part of drug selection for pharmacists and physicians. However, these evaluations can be complicated, time-consuming, and, if the data used are not based on local conditions, misleading. The computer program Dare to Compare 98 was developed to provide an analysis of empiric antibiotic regimens. The Infectious Disease Challenge portion of the program lists the commonly identified pathogens in specific infectious diseases. The Antibiogram Susceptibility Reports section generates susceptibility reports based on local antibiogram data or data from institutions nationwide that have similar demographic profiles. Susceptibility information is combined with cost data in the Quality/Cost Index section. Comparison of the quality and cost index values allows the user to determine which regimens provide the optimal microbiologic activity and cost values for treatment of a particular infectious disease based on local data. Thus Dare to Compare 98 can help pharmacists and physicians evaluate antibiotic regimens and their suitability for inclusion in formularies and disease-management algorithms.

Anti-Bacterial Agents↗

PubMed1998

Therapy cost 2000: an electronic tool for evaluating the cost-effectiveness of therapeutic regimens.

Providing quality care to patients at the lowest cost is of primary concern to hospitals, clinics, managed care organizations, integrated health systems, and other health care providers operating in a prospective payment environment. Therapy Cost 2000 can help health care providers and decision-makers in a variety of settings reach the goal of cost-effective, high-quality patient care.

Cost-Benefit Analysis↗

PubMedDate not supplied

A new tool for predicting erectile dysfunction.

The Sexual Health Inventory for Men (SHIM) is an effective way to assess erectile difficulty (ED). Despite documented efficacy, however, many physicians may be reluctant to incorporate it into clinical practice because of the intimate nature of the questionnaire. In an attempt to devise and test an easy-to-use computer-based SHIM score indicator for office use, more than 30,000 SHIM questionnaires were administered to men visiting physicians' offices in 2000. Information about age, current smoking status, diabetes, depression, hypertension, prostate disease, and cholesterol levels was also collected. A logistic regression model with a sensitivity of 81.8% and a specificity of 57.7% was created to predict the likelihood of ED in a patient scoring below 21 (SHIM definition). This model was built into a highly graphic Windows-based program. The SHIM score indicator is a convenient way to rapidly identify patients at high risk for ED who should be further assessed.

Adult↗